FEATURES OF ANDROGEN MЕTABOLISM IN COMMON DISEASES IN MEN OF REPRODUCTIVE AGE
Abstract
Introduction. Metabolism disorders in men of reproductive age common problem, its causes and relationship with other diseases and pathological conditions have not been studied
enough. Aim and objectives. To study the features of the metabolism of androgens in men of reproductive age with various endocrine and common chronic diseases. To detect the presence
and severity of the disturbance of androgen metabolism and to develop recommendations for correction of androgen metabolism disorders. Materials and methods. The study included
160 male patients aged 25–45 years. 40 of them at the time of the study were diagnosed type 2 diabetes, 20 – with 2–3 degrees of obesity, 20 – with uncompensated primary hypothyroidism,
20 – with compensated primary hypothyroidism, 20 – with chronic prostatitis prostatitis without exacerbation, 20 – with prostate adenoma, 20 – with chronic bronchitis mediated by smoking (other patients from 6 groups were non-smokers). The levels of luteinizing hormone, follicle stimulating hormone, testosterone and its active metabolite dihydrotestosterone, levels of the blood estradiol, and thyroidotropic hormone and thyroxine levels were also investigated to identify patients with hypothyroidism (as well as for the determination of hypothyroidism compensation). The level of glycated hemoglobin was studied in patients with type 2 diabetes mellitus to determine the degree of compensation of carbohydrate metabolism disorders; patients with diabetes mellitus were divided into two subgroups: 1 — glycated hemoglobin level is up to 7.5%; 2 —glycated hemoglobin level is more than 7.5%. Results. The risk of development of androgen metabolism disorders increases in patients with type 2 diabetes mellitus (the most expressed risk was found in uncompensated diabetes mellitus patients), obesity, prostate adenoma, chronic prostatitis, and with uncompensated hypothyroidism; compensation of hypothyroidism leads to the restoration of androgen metabolism. Among patients with chronic bronchitis, no obvious androgen metabolism disorders were found. Conclusions. Violation of androgen metabolism has a fairly high prevalence in various chronic diseases and endocrine disorders.
References
Аляева Ю.Г. Болезни предстательной железы. М.: ГЭОТАР‑Медиа; 2009.
Верткин А.Л., Пушкарь Д.Ю., Тополянский А.В. Эректильная дисфункция. Урология и нефрология. 2010.
Калинченко С.Ю., Тюзиков И.А., Ворслов О.Л., Тишова Ю.А. Бессимптомная доброкачественная гиперплазия предстательной железы: лечить или не лечить? Эффективная фармакотерапия. Урология. 2012;4:50–53.
Калинченко С.Ю., Тюзиков И.А., Греков Е.А. и др. Метаболический синдром и доброкачественная гиперплазия предстательной железы: единство патофизиологических механизмов и новые перспективы патогенетической терапии Consilium Medicum. 2012;7:19–24.
Калинченко С.Ю., Тюзиков И.А., Греков Е.А. и др. Комбинированная терапия андрогенами и ингибиторами 5α‑редуктазы в лечении пациентов ДГПЖ с возрастным гипогонадизмом: целесообразность, эффективность и безопасность Consilium Medicum. 2012;7:10–18.
Нишлаг Э., Бере Г.М. Андрология Мужское здоровье и дисфункция репродуктивной системы. 2005.
Тюзиков И.А., Мартов А.Г., Греков Е.А. Взаимосвязь компонентов метаболического синдрома и гормональных нарушений в патогенезе заболеваний предстательной железы. Экспериментальная и клиническая урология. 2012;3:39–46.
Тюзиков И.А., Фомин А.М., Калинченко С.Ю., Мартов А.Г. Системные механизмы патогенеза заболеваний предстательной железы. Андрология и генитальная хирургия. 2012;2:4–12.
Тюзиков И.А., Калинченко С.Ю., Ворслов Л.О., Тишова Ю.А. Место андрогенного дефицита в клиническом портрете современного урологического пациента. Андрология и генитальная хирургия. 2013;3:48–57.
Калинченко С.Ю., Тюзиков И.А. Заболевания предстательной железы и метаболический синдром: новая патогенетическая концепция. Медицинский алфавит. Больница. 2011;4:38–43.
Krassas G.E., Tziomalos K., Papadopolou F. et al. Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat. J Clin Endocrinol Metab. 2008;93(5):1815–1819.
Mendis-Handagama S.M., Siril-Ariyaratne H.B. Leidig cells, thyroid hormones and steroidogenesis. Ind J Experim. Biol. 2005;43:939–962.
